Back
Janux Therapeutics, Inc. Stock Predictions
Coinbase Lost $400M. Your Crypto Isn't Safe on Exchanges.
Stop trusting exchanges. Learn how to access Native Markets where YOU control your assets
Sell
29
JANX
Janux Therapeutics, Inc.
Last Price:
$15.33
Seasonality Move:
87.58%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Janux Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Janux Therapeutics, Inc. has on average historically risen by 63.3% based on the past 4 years of stock performance.
-
Janux Therapeutics, Inc. has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Janux Therapeutics, Inc. Stock Undervalued?The current Janux Therapeutics, Inc. [JANX] share price is $15.14. The Score for JANX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Janux Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Janux Therapeutics, Inc. has on average historically risen by 63.3% based on the past 4 years of stock performance.
Janux Therapeutics, Inc. Stock Rating
Sell
29
Janux Therapeutics, Inc. (JANX)
is a Sell
Is Janux Therapeutics, Inc. overpriced?
-
Janux Therapeutics, Inc. has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Janux Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
januxrx.com
52-Week Data
52-Week High:
47.58
52-Week Low:
12.80
Prediction Charts
Market Cap:
918.5M
Price in USD:
15.14
Volume:
6.2M
Beta:
2.93
Technical Analysis
SMA50:
19.52
SMA100:
22.28
SMA200:
23.98
52-Wk Change:
-62.32%
Stock Predictions
-
Is Janux Therapeutics, Inc. stock public?Yes, Janux Therapeutics, Inc. is a publicly traded company.
-
What is the Janux Therapeutics, Inc. stock quote today?The Janux Therapeutics, Inc. stock price is 15.14 USD today.
-
How to buy Janux Therapeutics, Inc. stock online?You can buy Janux Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-31 | 13.83 | 13.80 | 13.92 | 13.62 |
| Jan-5 | 13.57 | 13.75 | 13.79 | 13.28 |
| Jan-6 | 13.61 | 13.44 | 13.67 | 13.26 |
| Jan-7 | 13.48 | 13.98 | 14.30 | 13.48 |
| Jan-8 | 13.76 | 13.91 | 14.06 | 13.64 |
| Jan-9 | 13.91 | 14.16 | 14.25 | 13.91 |
| Jan-12 | 14.14 | 14.03 | 14.20 | 13.68 |
| Jan-13 | 14.02 | 13.79 | 14.06 | 13.75 |
| Jan-14 | 13.79 | 14.12 | 14.34 | 13.73 |
| Jan-15 | 14.21 | 13.72 | 14.21 | 13.55 |
| Jan-16 | 13.67 | 13.76 | 13.88 | 13.51 |
| Jan-20 | 13.11 | 13.15 | 13.36 | 12.80 |
| Jan-21 | 13.15 | 13.27 | 13.62 | 13.11 |
| Jan-22 | 13.79 | 15.14 | 15.28 | 13.46 |
Janux Therapeutics, Inc. Earnings
Janux Therapeutics, Inc. Earnings Report: Per Share Janux Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Janux Therapeutics, Inc. Forecast Revenue Growth
Janux Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Janux Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.01 per share, and a decrease next year of $0.83 per share.
* Janux Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.